AzTrials
AzTrials

Primary DysmenorrheaNCT07859124

Whole-Body Vibration and Aerobic Exercise for Primary Dysmenorrhea in Young Adult Women

A study testing Whole-Body Vibration Training and Aerobic Exercise Training in people with Primary Dysmenorrhea, run by Gaziantep Islam Science and Technology University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

The aim of this clinical trial is to learn how whole-body vibration training and aerobic exercise training affect menstrual pain, symptom severity, and quality of life in young adult women with primary dysmenorrhea. Primary dysmenorrhea is menstrual pain that occurs without an underlying medical condition. Read more about this study

Who is it for?
Ages 18 to 28 years, women only
Conditions the study is for
Primary Dysmenorrhea
What is being tested?
Whole-Body Vibration Training and Aerobic Exercise Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
No sites listed yet
Study dates
Oct 2026to 10 Feb 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 28 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Aged 18-28 years.
  • A female student enrolled in the Physiotherapy Program at the Vocational School of Health Services, Gaziantep Islam Science and Technology University.
  • Reports cramping pain in the lower abdomen during menstruation in at least four menstrual cycles within the past six months.
  • Reports menstrual pain that begins a few hours before or shortly after the onset of menstrual bleeding.
  • Has regular menstrual cycles of 21-35 days, with menstrual bleeding lasting 3-7 days.
  • Has a body mass index (BMI) of 18.5-30 kg/m².
Show all 9Show fewer
  • Is sedentary and does not exercise regularly.
  • Agrees to participate voluntarily and signs the informed consent form.
  • Has no mental, psychological, or neurological condition that would prevent them from understanding the assessments.

Who cannot join

  • A history of a gynecological condition that may cause secondary dysmenorrhea, such as endometriosis, adenomyosis, or pelvic inflammatory disease.
  • Regular use of hormonal medications, oral contraceptives, or analgesics within the past three months.
  • A history of a systemic or chronic disease, such as cardiovascular disease, thyroid disease, diabetes, or a neurological, endocrine, or rheumatological condition.
  • Smoking or alcohol use.
  • Being a professional athlete or exercising regularly.
  • Pregnancy or breastfeeding.
  • An orthopedic condition or balance problem that prevents exercise, such as vertigo, a fracture within the past six months, or surgery within the past six months.

About this study

Official title: Effects of Whole-Body Vibration and Aerobic Exercise Training on Pain, Symptom Severity, and Quality of Life in Young Adult Women With Primary Dysmenorrhea

The aim of this clinical trial is to learn how whole-body vibration training and aerobic exercise training affect menstrual pain, symptom severity, and quality of life in young adult women with primary dysmenorrhea. Primary dysmenorrhea is menstrual pain that occurs without an underlying medical condition. It can interfere with daily activities and quality of life. Exercise may help manage menstrual pain, but more information is needed about the effects of different exercise approaches.

This study will examine the effects of whole-body vibration training and aerobic exercise training in young adult women with primary dysmenorrhea. Researchers will assess menstrual pain, the severity of menstrual symptoms, and quality of life. The findings may help inform exercise-based approaches to managing primary dysmenorrhea.

Read the detailed description

A total of 66 female student volunteers aged 18-29 years with primary dysmenorrhea who meet the eligibility criteria will be enrolled. Participants will be assigned to one of two groups: the Whole-Body Vibration Training Group (WBV) or the Aerobic Exercise Training Group (AE).

Both exercise programs will last eight weeks and will be conducted three days per week, for a total of 24 sessions. Participants in the WBV group will receive whole-body vibration training, while participants in the AE group will receive aerobic exercise training.

Being tested
Whole-Body Vibration Training, Aerobic Exercise Training
Keywords
Primary dysmenorrhea, Menstrual pain, Whole-body vibration training, Aerobic exercise, Exercise therapy
Medical subject headings
Dysmenorrhea

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Whole-Body Vibration TrainingOther

    Participants in this group will receive whole-body vibration training three days per week for eight weeks, for a total of 24 sessions. The vibration frequency will be set at 14 Hz and the amplitude at 8 mm. Each session will last approximately 45 minutes.

  • Aerobic Exercise TrainingOther

    Participants in this group will receive aerobic exercise training three days per week for eight weeks. Each 45-minute session will consist of a 10-minute warm-up, 30 minutes of aerobic exercise, and 5 minutes of cool-down and stretching exercises.

Study groups in NCT07859124
Study groupRoleWhat they receive
Whole-Body Vibration Training GroupExperimentalThis programs will last 8 weeks, with exercise sessions 3 days per week.
Receives: Other: Whole-Body Vibration Training
Aerobic Exercise Training GroupExperimentalThis programs will last 8 weeks, with exercise sessions 3 days per week.
Receives: Other: Aerobic Exercise Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale

    Pain intensity will be assessed using a 10-cm Visual Analog Scale. Participants will mark the point on the line that best represents the intensity of their menstrual pain. The left endpoint represents "no pain," and the right endpoint represents "the worst pain imaginable." The distance from the left endpoint to the mark will be measured in centimeters, yielding a score from 0 to 10. Higher scores indicate more severe pain.

    Measured: Change from Baseline at 8 weeks

  2. Menstrual Symptom Questionnaire

    The Menstrual Symptom Questionnaire will be used to assess menstrual pain and symptom severity. It is a 24-item scale with five response options for each item. Participants will rate how often they experience each menstruation-related symptom, from 1 ("never") to 5 ("always"). The score is calculated as the mean of the 24 item scores and ranges from 1 to 5. Higher mean scores indicate more severe menstrual symptoms.

    Measured: Change from Baseline at 8 weeks

Secondary outcomes (1)
  1. 12-Item Short-Form Health Survey

    The 12-Item Short Form Health Survey (SF-12) will be used to assess health-related quality of life. The Mental Component Summary score will be calculated according to the scoring method specified in the study protocol. The SF-12 contains 12 questions covering eight domains: physical functioning, role limitations due to physical health, role limitations due to emotional problems, bodily pain, social functioning, mental health, vitality, and general health. Each domain score ranges from 0 to 100. Higher scores indicate better mental health.

    Measured: Change from Baseline at 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Oct 2026
  2. Study startOct 2026 (estimated)
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion10 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07859124
Sponsor's protocol ID
GIBTU-FTR--BT-2
Other IDs
1919B012502494
Status last verified
Sep 2026
First submitted
29 Sep 2026
Last updated
5 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Whole-Body Vibration Training and Aerobic Exercise Training in people with Primary Dysmenorrhea, run by Gaziantep Islam Science and Technology University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (time frame: Change from Baseline at 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in